These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2296651)

  • 1. P-31 MR spectroscopy of normal human brain and brain tumors.
    Hubesch B; Sappey-Marinier D; Roth K; Meyerhoff DJ; Matson GB; Weiner MW
    Radiology; 1990 Feb; 174(2):401-9. PubMed ID: 2296651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phosphorus-31 MR spectroscopy of brain tumors].
    Miyamachi K; Abe H; Miyasaka K
    No Shinkei Geka; 1990 Jun; 18(6):533-7. PubMed ID: 2395512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of 31P MR spectroscopy to the brain tumors.
    Ha DH; Choi S; Oh JY; Yoon SK; Kang MJ; Kim KU
    Korean J Radiol; 2013; 14(3):477-86. PubMed ID: 23690717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-dimensional phosphorus-31 chemical shift imaging of human brain tumors.
    Rutter A; Hugenholtz H; Saunders JK; Smith IC
    Invest Radiol; 1995 Jun; 30(6):359-66. PubMed ID: 7490188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment.
    Segebarth CM; Balériaux DF; Arnold DL; Luyten PR; den Hollander JA
    Radiology; 1987 Oct; 165(1):215-9. PubMed ID: 3628774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased phosphorus metabolite concentrations and alkalosis in chronic cerebral infarction.
    Sappey-Marinier D; Hubesch B; Matson GB; Weiner MW
    Radiology; 1992 Jan; 182(1):29-34. PubMed ID: 1727305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
    Luan W; Zhang J
    Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical MRS studies of the brain.
    Hubesch B; Marinier DS; Hetherington HP; Twieg DB; Weiner MW
    Invest Radiol; 1989 Dec; 24(12):1039-42. PubMed ID: 2558086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of in vivo phosphorus metabolites in human brain with magnetic resonance spectroscopic imaging (MRSI).
    Lara RS; Matson GB; Hugg JW; Maudsley AA; Weiner MW
    Magn Reson Imaging; 1993; 11(2):273-8. PubMed ID: 8455438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
    Tong Z; Yamaki T; Harada K; Houkin K
    Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy.
    Taylor-Robinson SD; Sargentoni J; Mallalieu RJ; Bell JD; Bryant DJ; Coutts GA; Morgan MY
    Hepatology; 1994 Nov; 20(5):1173-8. PubMed ID: 7927249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy.
    Meyerhoff DJ; Boska MD; Thomas AM; Weiner MW
    Radiology; 1989 Nov; 173(2):393-400. PubMed ID: 2798871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors.
    Tien RD; Lai PH; Smith JS; Lazeyras F
    AJR Am J Roentgenol; 1996 Jul; 167(1):201-9. PubMed ID: 8659372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
    Bruhn H; Frahm J; Gyngell ML; Merboldt KD; Hänicke W; Sauter R; Hamburger C
    Radiology; 1989 Aug; 172(2):541-8. PubMed ID: 2748837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human brain tumors: assessment with in vivo proton MR spectroscopy.
    Ott D; Hennig J; Ernst T
    Radiology; 1993 Mar; 186(3):745-52. PubMed ID: 8430183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatomyositis: correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease.
    Park JH; Vansant JP; Kumar NG; Gibbs SJ; Curvin MS; Price RR; Partain CL; James AE
    Radiology; 1990 Nov; 177(2):473-9. PubMed ID: 2217788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
    Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
    J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.